Early antipsychotic intervention and schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Developmental Psychology

Background:

• Schizophrenia is a severe mental disorder characterized by cognitive deterioration.
• Antipsychotic medications are effective but the optimal timing for initiating treatment, especially in the premorbid stage, remains debated.
• The developmental origins of schizophrenia suggest early intervention may be beneficial for high-risk individuals.

Purpose of the Study:

• To investigate the efficacy of early pharmacological intervention for schizophrenia.
• To test the hypothesis that early treatment can reverse sensorimotor gating deficits, a potential preclinical marker for schizophrenia.
• To compare the effectiveness of interventions initiated at different developmental stages.

Main Methods:

• A pilot rodent study was conducted using isolation rearing to induce sensorimotor gating deficits.
• Chronic administration of risperidone was initiated at different age time points (adolescent vs. young adult stages).
• Sensorimotor gating dysfunction was assessed to evaluate the impact of risperidone treatment.

Main Results:

• Chronic risperidone treatment reversed isolation rearing-induced sensorimotor gating dysfunction.
• Interventions initiated during the adolescent stage demonstrated greater efficacy compared to those started four weeks later in young adulthood.
• These findings support the potential benefits of early pharmacological intervention.

Conclusions:

• Early pharmacological intervention, specifically with risperidone, can be effective in reversing sensorimotor gating deficits associated with schizophrenia risk.
• Initiating treatment during adolescence appears more beneficial than delaying it until young adulthood.
• The study provides novel insights into the prevention and treatment strategies for schizophrenia, emphasizing the importance of early intervention.